Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Vassiliki Douka"'
Autor:
Eleni Gavriilaki, Athanasios Tragiannidis, Maria Papathanasiou, Sotiria Besikli, Paraskevi Karvouni, Vassiliki Douka, Eleni Paphianou, Emmanuel Hatzipantelis, Giorgos Papaioannou, Anastasia Athanasiadou, Anastasia Marvaki, Alkistis-Kira Panteliadou, Anna Vardi, Ioannis Batsis, Antonia Syrigou, Despina Mallouri, Chrysavgi Lalayanni, Ioanna Sakellari
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Bone marrow failure (BMF) syndromes are a group of various hematological diseases with cytopenia as a main common characteristic. Given their rarity and continuous progress in the field, we aim to provide data considering the efficiency and safety of
Externí odkaz:
https://doaj.org/article/d093d871dfea4f08bb96ab473a6c905b
Autor:
Eleni Gavriilaki, Ioanna Sakellari, Despina Mallouri, Ioannis Batsis, Thomas Chatziconstantinou, Anna Vardi, Zoi Bousiou, Marianna Masmanidou, Vassiliki Douka, Antonia Syrigou, Damianos Sotiropoulos, Varnavas Constantinou, Achilles Anagnostopoulos
Publikováno v:
HemaSphere, Vol 4, Iss 2, p e345 (2020)
Externí odkaz:
https://doaj.org/article/601cf70e666e4e22b672ee5b27697ce8
Autor:
Styliani I. Kokoris, Anastasia Athanasiadou, Georgios Papaioannou, Niki Vyrides, Eleni Gavriilaki, Achilles Anagnostopoulos, Sofia Neofytou, Yiannis Vyrides, Vassiliki Douka, Chrysavgi Lalayanni
Publikováno v:
Cancer Genetics. :1-5
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare life-threatening disease resulting from clonal hematopoietic stem cell evolution. There is a strong link between PNH and other acquired bone marrow failure syndromes, including myelodysplastic syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f985fd4d48e603f5322e2c055a4a17e
https://doi.org/10.1016/j.cancergen.2020.11.001
https://doi.org/10.1016/j.cancergen.2020.11.001
Autor:
Eleni Gavriilaki, Achilles Anagnostopoulos, Vassiliki Douka, Penelope Georgia Papayanni, Christos Demosthenous, Ioanna Sakellari
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 2050, p 2050 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Background: Myeloid-derived suppressor cells (MDSCs) are implicated in the complex interplay involving graft-versus-leukemia (GVL) effects and graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HCT) in hem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f4486ae23bb6e38f1796d3236140be
https://www.mdpi.com/2077-0383/10/10/2050
https://www.mdpi.com/2077-0383/10/10/2050
Autor:
Marie-Christine Kyrtsonis, Meletios A. Dimopoulos, Evangelos Eleutherakis-Papaiakovou, Athanasios Papatheodorou, Eirini Katodritou, Polyzois Makras, Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, Nikolaos Kanellias, Emmanouil Spanoudakis, Vassiliki Douka
Publikováno v:
Cancers
Volume 13
Issue 6
Cancers, Vol 13, Iss 1257, p 1257 (2021)
Volume 13
Issue 6
Cancers, Vol 13, Iss 1257, p 1257 (2021)
Carfilzomib with dexamethasone (Kd) is a well-established regimen for the treatment of relapsed/refractory multiple myeloma (RRMM). There is limited information for the effects of Kd on myeloma-related bone disease. This non-interventional study aime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75fcd83999391c547337d7360ac7302e
Autor:
Vassiliki Douka, Maria Papathanasiou, Vasilis Gianouzakos, Michalis Iskas, Anastasia Athanasiadou, Chrysavgi Lalayanni, Chrysa Apostolou, Zoi Bousiou, Achilles Anagnostopoulos, Stella Bouziana, Despina Mallouri, Eleni Gavriilaki, Varnavas Constantinou, Konstantinos Chatziioannou, Evangelia Yannaki, Damianos Sotiropoulos, Ioanna Sakellari, Ioannis Batsis
Publikováno v:
Annals of Hematology. 97:1987-1994
The role of total body irradiation (TBI) in allogeneic hematopoietic stem cell transplantation (HCT) for adult acute lymphoblastic leukemia (ALL) remains controversial. Therefore, we investigated long-term treatment outcomes of transplanted ALL patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b00c86b87664f2fbcde0b3f0542715
https://doi.org/10.1007/s00277-018-3383-9
https://doi.org/10.1007/s00277-018-3383-9
Autor:
Eleni Gavriilaki, Marianna Masmanidou, Varnavas Constantinou, Vassiliki Douka, Zoi Bousiou, Anna Vardi, Thomas Chatziconstantinou, Achilles Anagnostopoulos, Damianos Sotiropoulos, Ioannis Batsis, Antonia Syrigou, Despina Mallouri, Ioanna Sakellari
Publikováno v:
HemaSphere
HemaSphere, Vol 4, Iss 2, p e345 (2020)
HemaSphere, Vol 4, Iss 2, p e345 (2020)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cba4cd580863455f64c5e5fa2dbe54d
https://pubmed.ncbi.nlm.nih.gov/32309782
https://pubmed.ncbi.nlm.nih.gov/32309782
Autor:
Chrysavgi Lalayanni, Michalis Iskas, Achilles Anagnostopoulos, Nikoleta Pastelli, Christos Demosthenous, Vassiliki Douka
Publikováno v:
Current problems in cancer. 43(3)
Blinatumomab, a bispecific T-cell engager antibody construct targeting CD19, has been shown to improve the outcome in patients with relapsed and/or refractory B-cell acute lymphoblastic leukemia. Treatment with blinatumomab demonstrated significant s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0807dfd8b02bf3ab30eea10c09570a6c
https://pubmed.ncbi.nlm.nih.gov/29895435
https://pubmed.ncbi.nlm.nih.gov/29895435
Autor:
Ioannis Adamopoulos, Maria Kotsopoulou, Evangelos Terpos, Anna Kioumi, Eftychia Nikolaou, Panagiotis Zikos, Eleni Papadaki, Panayiotis Repousis, Eirini Katodritou, Georgios Vasilopoulos, Vassiliki Douka, Evangelos Briasoulis, Emmanouil Spanoudakis, Anthi Aktypi, Dimitrios Gogos, Sosana Delimpasi, Despoina Fotiou, Aikaterini Megalakaki, Eleftheria Hatzimichael, Kyriaki Kokoviadou, Marie-Christine Kyrtsonis, Achilles Anagnostopoulos, Argiris Symeonidis, Vassiliki Pappa, Evlambia Giannopoulou, Despoina Timotheatou, Nikolaos Giannakoulas, D.S. Kyriakou
Publikováno v:
Annals of Hematology
We evaluated progression-free survival (PFS) rate of patients treated with lenalidomide/dexamethasone (Len/Dex), the efficacy of the combination, and the prognostic significance of treatment at biochemical vs. clinical relapse on PFS in 207 consecuti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6778a715b94bdabba13a19cecdbff30e
https://pubmed.ncbi.nlm.nih.gov/29943159
https://pubmed.ncbi.nlm.nih.gov/29943159
Autor:
A. Chatziioannidis, Varvara Tachynopoulou, K. Kotta, A. Athanasiadou, A. Tsompanakou, C. Lalayanni, M. Iskas, C. Vadikolia, M. Papathanasiou, Antonia Syrigou, R. Avramidou, Vassiliki Douka, Achilles Anagnostopoulos
Publikováno v:
HemaSphere. 3:47-48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c32c634c4368db3601951f2714e7e3b6
https://doi.org/10.1097/01.hs9.0000558980.00592.f4
https://doi.org/10.1097/01.hs9.0000558980.00592.f4